Delivery Order SPE2DR25D1100-SPE2DR26FDD2H
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13.5 million to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 20, 2026, with completion scheduled for January 21, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,076.40 to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of RINVOQ ER 30 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order will be fulfilled at the company's Conshohocken, Pennsylvania location and is scheduled for completion by February 4, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. This delivery order...
- The Defense Logistics Agency awarded a $19,675.26 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of RINVOQ ER 15mg tablets (30-count bottles). This is a firm fixed-price, non-set-aside contract with a completion date of January 14, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...
- The Defense Logistics Agency awarded a delivery order valued at $104,045.83 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on January 29, 2026, with completion targeted for January 30, 2026. This firm fixed-price, non-set-aside contract is executed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $15,284.45 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-tablet units). This firm fixed-price contract, which is not set-aside for any specific business type, is scheduled for completion by January 14, 2026, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement executed under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $13,116.80 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,762.36 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $45,798 delivery order to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,807.47 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,558.42 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of RINVOQ ER 15mg tablets (30-count supply). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order is issued...